TBCRC 030: A randomized phase II study of preoperative cisplatin versus paclitaxel in TNBC-Evaluating the homologous recombination deficiency (HRD) biomarker Meeting Abstract
| Authors: | Mayer, E. L.; Abramson, V. G.; Jankowitz, R. C.; Falkson, C. I.; Marcom, P. K.; Traina, T. A.; Carey, L. A.; Rimawi, M. F.; Specht, J. M.; Miller, K.; Stearns, V.; Perou, C. M.; Richardson, A. L.; Tung, N. M.; Barry, W. T.; Tan-Wasielewski, Z.; Timms, K.; Hartman, A. R.; Wolff, A. C.; Winer, E. P. |
| Abstract Title: | TBCRC 030: A randomized phase II study of preoperative cisplatin versus paclitaxel in TNBC-Evaluating the homologous recombination deficiency (HRD) biomarker |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 10s |
| Language: | English |
| ACCESSION: | WOS:000487345803500 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.507 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 507 -- Source: Wos |
